ConductScience.org, home

Paper8733486

Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.

Mukhopadhyay S and 5 others. Thorax, 1996. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Papers, record 8733486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8733486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.
PubMed
Journal
Thorax
PubMed
Year
1996
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
3.45
iCite
Revised in PubMed
2022-02-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mukhopadhyay SS
2Singh MM
3Cater JIJ I
4Ogston SS
5Franklin MM
6Olver RER E

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Cystic FibrosisMajor topic
Pseudomonas InfectionsMajor topic
Administration, Inhalation
Drug Resistance, Microbial
Hearing
Humans
Kidney
Randomized Controlled Trials as Topic
Spirometry

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in8994535Nebulised antipseudomonal therapy in cystic fibrosis.https://conductscience.org/library/papers/8994535PubMed
Comment in9196534Nebulised antipseudomonal antibiotic therapy in cystic fibrosis.https://conductscience.org/library/papers/9196534PubMed

Download CSV of comments and corrections

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16118579Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.Lancet1981https://conductscience.org/library/papers/6118579PubMed
26981383Pseudomonas infection, allergy, and cystic fibrosis.Arch Dis Child1982https://conductscience.org/library/papers/6981383PubMed
310141711The Cochrane Collaboration: the role of the UK Cochrane Centre in identifying the evidence.Health Libr Rev1994https://conductscience.org/library/papers/10141711PubMed
46134106Inhaled antibiotics in cystic fibrosis.Lancet1983https://conductscience.org/library/papers/6134106PubMed
56466215Nebulized gentamicin in children and adolescents with cystic fibrosis.Aust Paediatr J1984https://conductscience.org/library/papers/6466215PubMed
63992068A measure to aid in the interpretation of published clinical trials.Stat Med1985https://conductscience.org/library/papers/3992068PubMed
73517274Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect?J Pediatr1986https://conductscience.org/library/papers/3517274PubMed
83802833Meta-analysis in clinical trials.Control Clin Trials1986https://conductscience.org/library/papers/3802833PubMed
93301785Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.J Antimicrob Chemother1987https://conductscience.org/library/papers/3301785PubMed
103329531A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis.Br J Dis Chest1987https://conductscience.org/library/papers/3329531PubMed
112494640Long-term tobramycin aerosol therapy in cystic fibrosis.Pediatr Pulmonol1989https://conductscience.org/library/papers/2494640PubMed
122505216Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.Pediatr Pulmonol1989https://conductscience.org/library/papers/2505216PubMed
132251263Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2251263PubMed
141671425Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.Lancet1991https://conductscience.org/library/papers/1671425PubMed
151357002
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
J Clin Invest1992https://conductscience.org/library/papers/1357002PubMed
168497284Efficacy of aerosolized tobramycin in patients with cystic fibrosis.N Engl J Med1993https://conductscience.org/library/papers/8497284PubMed
178301420Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference.J Pediatr1994https://conductscience.org/library/papers/8301420PubMed
188120703Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials.J Pediatr1994https://conductscience.org/library/papers/8120703PubMed
198036286When will nebulized chemotherapy come of age?Respir Med1994https://conductscience.org/library/papers/8036286PubMed
207718048Identifying relevant studies for systematic reviews.BMJ1994https://conductscience.org/library/papers/7718048PubMed

Download CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
36254907Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population.Ann Card Anaesth2022https://conductscience.org/library/papers/36254907PubMed
33869120Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years.Front Pediatr2021https://conductscience.org/library/papers/33869120PubMed
28807905Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28807905PubMed
26306111Inhaled therapy in cystic fibrosis: agents, devices and regimens.Breathe (Sheff)2015https://conductscience.org/library/papers/26306111PubMed
25278817Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.Core Evid2014https://conductscience.org/library/papers/25278817PubMed
19145262Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.Can J Infect Dis Med Microbiol2008https://conductscience.org/library/papers/19145262PubMed
18046534Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects.Intensive Care Med2008https://conductscience.org/library/papers/18046534PubMed
12876172Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.Arch Dis Child2003https://conductscience.org/library/papers/12876172PubMed
12513105Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.Paediatr Drugs2003https://conductscience.org/library/papers/12513105PubMed
12083973Nebulized antibiotics in cystic fibrosis.Paediatr Drugs2002https://conductscience.org/library/papers/12083973PubMed
11420207Recent advances in cystic fibrosis.Arch Dis Child2001https://conductscience.org/library/papers/11420207PubMed
11316693Bronchoconstriction following nebulised colistin in cystic fibrosis.Arch Dis Child2001https://conductscience.org/library/papers/11316693PubMed
10651624Influence of a pulmonary surfactant on the in vitro activity of tobramycin against Pseudomonas aeruginosa.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10651624PubMed
10212099Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis.Thorax1999https://conductscience.org/library/papers/10212099PubMed
10086932Is prolonged rotavirus infection a common cause of protracted diarrhoea?Arch Dis Child1999https://conductscience.org/library/papers/10086932PubMed
10086931Evidence for using nebulised antibiotics in cystic fibrosis.Arch Dis Child1999https://conductscience.org/library/papers/10086931PubMed
9872903Clinical outcome in relation to care in centres specialising in cystic fibrosis. Cross infection with Pseudomonas aeruginosa is unusual.BMJ1999https://conductscience.org/library/papers/9872903PubMed
9713010Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation.Arch Dis Child1998https://conductscience.org/library/papers/9713010PubMed
9709385Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.J R Soc Med1998https://conductscience.org/library/papers/9709385PubMed
9659359Lung infections. 3. Pseudomonas aeruginosa and other related species.Thorax1998https://conductscience.org/library/papers/9659359PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8733486

GET https://conductscience.org/api/papers/v1/8733486/cited_by?page=2